This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Donaldson, C. J. Articles by Vale, W. W. Search for Related Content PubMed PubMed Citation Articles by Donaldson, C. J. Articles by Vale, W. W. Pubmed/NCBI databases Substance via MeSH Hazardous Substances DB MENOTROPINS

Activin and Inhibin Binding to the Soluble Extracellular Domain of Activin Receptor II¹

The Clayton Foundation Laboratories for Peptide Biology, The Salk Institute, La Jolla, California 92037

Address all correspondence and requests for reprints to: Wylie Vale, Ph.D., The Clayton Foundation Laboratories for Peptide Biology, The Salk Institute, 10010 North Torrey Pines Road, La Jolla, California 92037. E-mail: vale{at}salk.edu

Activins and inhibins belong to the transforming growth factor-ß-like superfamily of growth and differentiation factors that exert pleiotropic effects in many target tissues. Heteromeric association of activin with two structurally related receptor serine/threonine kinases, activin receptor types I and II, initiates downstream signaling events. The extracellular domain of type II mouse activin receptor (ActRII ECD) was expressed in the baculovirus system, purified in three steps by lectin affinity, anion exchange, and reverse phase chromatography, and further characterized by mass spectrometry. The reduction in the apparent size of the purified ActRII ECD on SDS-PAGE after treatment with glycosidases provided evidence for N- and O-linked oligosaccharides. Specific receptor/ligand complexes of [¹²⁵I]activin A to ActRII ECD or [¹²⁵I]ActRII ECD to activin A were analyzed by cross-linking and immunoprecipitation. Two major radiolabeled bands were observed on SDS-PAGE with mobilities consistent with the expected size of ActRII ECD/ß_A or ActRII ECD/ß_Aß_A. When inhibin A was cross-linked to [¹²⁵I]ActRII ECD, a slower migrating complex corresponding to ActRII ECD/ß_A was also observed. The apparent dissociation constant (K_d) for activin A binding to ActRII ECD was 2–7 nM. This K_d value is approximately an order of magnitude greater than that of the full-length membrane-associated type II receptor. Treatment of cultured rat anterior pituitary cells with ActRII ECD attenuated FSH secretion in response to exogenous activin A or endogenous activin B. These data indicate that the soluble ActRII ECD has structural determinants that are sufficient for high affinity ligand binding.

This article has been cited by other articles:

				R. S. Pearsall, E. Canalis, M. Cornwall-Brady, K. W. Underwood, B. Haigis, J. Ucran, R. Kumar, E. Pobre, A. Grinberg, E. D. Werner, et al. A soluble activin Type IIA receptor induces bone formation and improves skeletal integrity PNAS, May 13, 2008; 105(19): 7082 - 7087. [Abstract] [Full Text] [PDF]

				Q. Li, R. Kumar, K. Underwood, A. E. O'Connor, K. L. Loveland, J. S. Seehra, and M. M. Matzuk Prevention of cachexia-like syndrome development and reduction of tumor progression in inhibin-deficient mice following administration of a chimeric activin receptor type II-murine Fc protein Mol. Hum. Reprod., September 1, 2007; 13(9): 675 - 683. [Abstract] [Full Text] [PDF]

				E. del Re, Y. Sidis, D. A. Fabrizio, H. Y. Lin, and A. Schneyer Reconstitution and Analysis of Soluble Inhibin and Activin Receptor Complexes in a Cell-free System J. Biol. Chem., December 17, 2004; 279(51): 53126 - 53135. [Abstract] [Full Text] [PDF]

				A. M. O. Leal, K. Takabe, L. Wang, C. J. Donaldson, L. A. MacConell, L. M. Bilezikjian, I. M. Verma, and W. Vale Effect of Adenovirus-Mediated Overexpression of Follistatin and Extracellular Domain of Activin Receptor Type II on Gonadotropin Secretion in Vitro and in Vivo Endocrinology, March 1, 2002; 143(3): 964 - 969. [Abstract] [Full Text] [PDF]

				P. C. Gray, J. Greenwald, A. L. Blount, K. S. Kunitake, C. J. Donaldson, S. Choe, and W. Vale Identification of a Binding Site on the Type II Activin Receptor for Activin and Inhibin J. Biol. Chem., February 4, 2000; 275(5): 3206 - 3212. [Abstract] [Full Text] [PDF]